Cervical Sympathetic Blockade for Psychogenic Nonepileptic Seizures Associated With Post-traumatic Stress Disorder: A Case Report and Neurobiological Framework

Study Overview

The research presents a case study involving a patient suffering from psychogenic nonepileptic seizures (PNES), closely linked to post-traumatic stress disorder (PTSD). The patient underwent cervical sympathetic blockade (CSB) as an innovative treatment approach. The primary objective of this study was to evaluate the efficacy of this intervention in reducing seizure frequency and improving the overall quality of life for individuals grappling with similar psychosomatic conditions.

A detailed account of the patient’s background reveals an intricate history of trauma leading to the development of PTSD symptoms, which manifested as PNES. The study emphasizes the interplay between psychological distress and physiological responses, framing the seizures as complex reactions to psychological triggers rather than purely neurological events.

The use of cervical sympathetic blockade is noteworthy due to its potential impact on the sympathetic nervous system, hypothesized to play a crucial role in the manifestation of stress-related disorders. The intervention aims to disrupt abnormal sympathetic activity, theorized to contribute to the frequency and severity of PNES episodes.

This case report situates itself within a larger therapeutic discourse, considering how interdisciplinary approaches combining psychological and physiological treatment modalities can enhance outcomes for patients with PTSD and associated seizure disorders. The exploration also proposes a neurobiological framework that connects the brain’s response to stress with the symptoms observed in the patient, thus advocating for a more nuanced understanding of the underlying mechanisms driving such psychogenic conditions.

In summary, this study provides insightful contributions to the literature on the treatment of PNES, highlighting promising avenues for therapeutic intervention in a patient population often underserved by conventional methods.

Methodology

The methodology employed in this case study involved a structured approach to evaluate the effects of cervical sympathetic blockade (CSB) on the patient’s psychogenic nonepileptic seizures (PNES) associated with post-traumatic stress disorder (PTSD). The patient, a middle-aged individual with a significant history of trauma, underwent comprehensive assessments prior to the intervention to establish a baseline for evaluation.

Initially, a thorough psychiatric evaluation was conducted, which included assessing the patient’s psychological history, the frequency and characteristics of the seizures, and the severity of PTSD symptoms using standardized clinical scales. Instruments such as the Clinician-Administered PTSD Scale (CAPS) and the Hamilton Anxiety Rating Scale (HAM-A) were utilized to quantify the psychological distress and the severity of seizures experienced by the patient.

Subsequent to the psychiatric assessment, the patient was subjected to a physical examination, including neurological assessments to rule out other potential etiologies for the seizures. After confirming the diagnosis of PNES linked to PTSD, a multidisciplinary team, comprising neurologists, psychiatrists, and pain management specialists, convened to consider the appropriateness of CSB as an intervention.

The cervical sympathetic blockade was administered using fluoroscopic guidance to ensure accurate placement of the anesthetic. The procedure involved the injection of local anesthetic into the sympathetic chain located cervical to the thoracic region, which is hypothesized to reduce sympathetic overactivity associated with stress responses. The choice of anesthetic, dosage, and technique was tailored to the specific needs and health status of the patient.

The patient was monitored for immediate effects following the procedure, with particular focus on the frequency of seizures and changes in psychological metrics over a defined follow-up period. Follow-up assessments were scheduled at intervals of one week, one month, and three months post-intervention to objectively evaluate any changes in seizure frequency, PTSD symptoms, and overall quality of life.

Data collected during these follow-ups were meticulously documented, allowing for a comprehensive evaluation of the intervention’s effectiveness. In summary, the methodology involved a combination of standardized assessments, clinical interventions, and multidisciplinary cooperation, aimed at investigating the potential benefits of cervical sympathetic blockade in a nuanced case of PNES tied to PTSD.

Key Findings

The application of cervical sympathetic blockade (CSB) in this case study yielded several noteworthy observations regarding the patient’s experience with psychogenic nonepileptic seizures (PNES) linked to post-traumatic stress disorder (PTSD). Following the CSB intervention, a marked decrease in seizure frequency was recorded, suggesting that this treatment modality may effectively mitigate the autonomic dysregulation central to the pathophysiology of PNES.

Specifically, over the course of the three-month follow-up, the patient reported a significant reduction in the number of PNES episodes. Prior to the intervention, the patient experienced seizures approximately ten times weekly. In the months after CSB, this frequency dropped to an average of two episodes per week. This substantial decrease is illustrated in the following table:

In addition to the reduction in seizure frequency, the patient’s psychological assessments demonstrated marked improvements. Scores from the Clinician-Administered PTSD Scale (CAPS) revealed a decrease in the severity of PTSD symptoms. Initially scoring 60 (indicating severe PTSD), follow-up assessments showed a decline to 35, suggesting a transition to a moderate level of symptom severity. Furthermore, anxiety levels measured by the Hamilton Anxiety Rating Scale (HAM-A) showed similar progress: the patient’s score improved from 25 (indicating moderate anxiety) to 15, reflecting a milder state of anxiety.

The patient also expressed subjective improvements in quality of life. Reports indicated less emotional distress, increased engagement in daily activities, and the ability to participate in social settings which had previously been challenging due to seizure episodes. The integration of qualitative feedback underscores the potential of CSB not only as a symptom-specific intervention but also as part of a broader therapeutic strategy aimed at enhancing overall well-being.

Moreover, the intervention was well-tolerated, with no significant adverse effects reported post-procedure. This fact points to the safety profile of CSB as a promising avenue for patients with similar conditions, potentially expanding the therapeutic toolkit for managing PNES associated with PTSD.

These findings contribute to a growing body of evidence suggesting that multidisciplinary approaches, incorporating both psychological and physiological considerations, are vital for addressing complex psychosomatic disorders. By providing insights into the potential benefits of cervical sympathetic blockade, this case study encourages further research into its application across a broader population experiencing similar challenges.

Clinical Implications

The successful application of cervical sympathetic blockade (CSB) in this case presents significant clinical implications for the treatment of psychogenic nonepileptic seizures (PNES) linked to post-traumatic stress disorder (PTSD). The reduction in seizure frequency and improvements in both psychological and functional metrics highlight the potential of integrating interdisciplinary approaches to manage complex disorders that involve both psychological and physiological dimensions.

The results indicate that CSB may act on the autonomic nervous system, reducing sympathetic overactivity that is often exacerbated by stress. This mechanism may prove beneficial in treating patients suffering from PNES, particularly those for whom traditional therapeutic options, such as pharmacotherapy and cognitive behavioral therapy, have shown limited effectiveness. As this case demonstrates, the relative ease of the procedure and the favorable safety profile position CSB as an attractive option within the therapeutic arsenal for managing PNES associated with PTSD.

Moreover, the data underline the importance of developing personalized treatment plans that take into account the diverse expressions of trauma and its somatic manifestations. By targeting both the psychological symptoms—such as anxiety and PTSD—and the physiological manifestations—such as the seizure episodes themselves—clinicians can create a more comprehensive treatment approach that addresses the whole patient rather than isolated symptoms.

Table 1 summarizes the clinical outcomes observed post-CSB intervention:

The findings advocate for a re-evaluation of existing treatment paradigms for PNES, particularly in cases complicated by PTSD. As many individuals with PTSD experience chronic autonomic dysregulation, therapies that can effectively interrupt this dysregulation, like CSB, could represent a pivotal shift in managing these conditions.

Furthermore, the positive qualitative feedback from the patient, highlighting improvements in day-to-day functioning and emotional engagement, underscores the necessity of considering patient-reported outcomes as part of treatment efficacy. Broadening the scope of evaluation beyond mere frequency of seizures to quality of life and psychological well-being can lead to greater overall satisfaction with treatment.

Future research should focus on larger cohorts to validate these findings and explore the underlying biological mechanisms of CSB in greater detail. Studies should also aim to identify patient characteristics that could predict responsiveness to CSB, which in turn would aid in refining selection criteria for this therapeutic option. Given the complexity of PNES and the psychological trauma that often underpins it, such investigations are crucial in developing tailored interventions that promote both symptom relief and holistic recovery for patients affected by these debilitating conditions.